Skip to content
Cryptos: 605Market Cap: $3.31T 3.8%24h Vol: $181.82BDominance: BTC 46.3% ETH 8.3%
Open Tradzy

New high · Switzerland stocks

Eli Lilly and Company (LLY) closes at a 52-week high of CHF 1,180.00

Its second new 52-week high in 5 sessions. Up 23.6% over 20 sessions.

Published 5 November 2026 · Written from Tradzy's price and volume data

Close
CHF 1,180.00
On the day
+1.7%
Volume
no average yet
vs 52-week high
New high

Eli Lilly and Company closing prices

CHF 900.00CHF 1,000.00CHF 1,100.00CHF 1,200.00Jul '26Jul '26Aug '26Sep '26Oct '26Nov '26CHF 1,180.00

The last 90 closes up to 5 November 2026. The live chart is on the LLY page.

What happened

Eli Lilly and Company (LLY) closed at CHF 1,180.00 on 5 November 2026, up 1.7% from CHF 1,160.00 the session before.

It is the second new high in the last 5 sessions. Over 5 sessions the price is up 4.4%, and over 20 sessions it is up 23.6%.

That close is above every close of the past year. The previous highest was CHF 1,170.00 on 30 Oct 2026, and the new close is 0.9% above it.

Across the 3 SWISS stocks we track, 3 closed higher and 0 closed lower that day, with a median change of +1.72%. LLY's change was +1.7%.

This page reports what the price and volume data show. It does not say why the price moved.

The numbers

Previous closeCHF 1,160.00
CloseCHF 1,180.00
Change on the day+1.72%
Change over 5 sessions+4.42%
Change over 20 sessions+23.56%
Volume1.00
Average volume, up to 20 sessions beforenot enough history
Volume against that averagenot enough history
Highest close in the past yearCHF 1,170.00 (30 Oct 2026)
Lowest close in the past yearCHF 680.00 (29 Apr 2026)

The full chart and history are on Eli Lilly and Company (LLY). More from this market: SWISS news today.

More SWISS moves on 5 November 2026

Want a plan for LLY? Open it in Tradzy: the Analyst Engine reads the chart and lays out an entry, a stop and targets, and you can practise the trade with paper money first.

Open Tradzy

Built from Tradzy's own price and volume data. It reports what the market did and does not say why. Nothing here is financial advice. See the disclaimer.